IMMUNITYBIO, INC. Revenue
IMMUNITYBIO, INC. (IBRX) reported Revenue of $51.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-08-04
- IMMUNITYBIO, INC. revenues for the quarter ending 2026-06-30 was $51.24M, a 93.91% increase year-over-year.
- IMMUNITYBIO, INC. revenues for the quarter ending 2026-03-31 was $44.21M, a 167.64% increase year-over-year.
- IMMUNITYBIO, INC. revenues for the quarter ending 2025-12-31 was $38.28M, a 406.95% increase year-over-year.
- IMMUNITYBIO, INC. revenues for the quarter ending 2025-09-30 was $32.06M, a 425.07% increase year-over-year.
- IMMUNITYBIO, INC. revenues for fiscal 2025 was $113.29M, a 668.31% increase from fiscal 2024.
- IMMUNITYBIO, INC. revenues for fiscal 2024 was $14.74M, a 2270.58% increase from fiscal 2023.
- IMMUNITYBIO, INC. revenues for fiscal 2023 was $622.00K, a 159.17% increase from fiscal 2022.
- IMMUNITYBIO, INC. revenues for fiscal 2022 was $240.00K, a 74.30% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $51.24M 10-Q · filed 2026-08-04 | $95.45M 10-Q · filed 2026-08-04 | $133.73M derived: sum of 3 quarters · filed 2026-08-04 | $165.79M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $44.21M 10-Q · filed 2026-05-07 | $82.49M derived: sum of 2 quarters · filed 2026-05-07 | $114.55M derived: sum of 3 quarters · filed 2026-05-07 | $140.98M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $38.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $70.35M derived: sum of 2 quarters · filed 2026-02-23 | $96.77M derived: sum of 3 quarters · filed 2026-08-04 | $113.29M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $32.06M 10-Q · filed 2025-11-05 | $58.49M derived: sum of 2 quarters · filed 2026-08-04 | $75.00M 10-Q · filed 2025-11-05 | $82.56M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $26.43M 10-Q · filed 2026-08-04 | $42.94M 10-Q · filed 2026-08-04 | $50.49M derived: sum of 3 quarters · filed 2026-08-04 | $56.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $16.52M 10-Q · filed 2026-05-07 | $24.07M derived: sum of 2 quarters · filed 2026-05-07 | $30.18M derived: sum of 3 quarters · filed 2026-05-07 | $31.22M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $7.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $13.66M derived: sum of 2 quarters · filed 2026-02-23 | $14.71M derived: sum of 3 quarters · filed 2026-02-23 | $14.74M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $6.11M 10-Q · filed 2025-11-05 | $7.15M derived: sum of 2 quarters · filed 2025-11-05 | $7.19M 10-Q · filed 2025-11-05 | $7.33M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $1.05M 10-Q · filed 2025-08-05 | $1.09M 10-Q · filed 2025-08-05 | $1.23M derived: sum of 3 quarters · filed 2026-02-23 | $1.31M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $40.00K 10-Q · filed 2025-05-12 | $179.00K derived: sum of 2 quarters · filed 2026-02-23 | $261.00K derived: sum of 3 quarters · filed 2026-02-23 | $302.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $221.00K derived: sum of 2 quarters · filed 2026-02-23 | $262.00K derived: sum of 3 quarters · filed 2026-02-23 | $622.00K 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $82.00K 10-Q · filed 2023-11-09 | $123.00K derived: sum of 2 quarters · filed 2023-11-09 | $483.00K 10-Q · filed 2023-11-09 | $556.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $41.00K 10-Q · filed 2023-08-08 | $401.00K 10-Q · filed 2023-08-08 | $474.00K derived: sum of 3 quarters · filed 2025-03-03 | $592.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $360.00K 10-Q · filed 2024-05-09 | $433.00K derived: sum of 2 quarters · filed 2025-03-03 | $551.00K derived: sum of 3 quarters · filed 2025-03-03 | $586.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $191.00K derived: sum of 2 quarters · filed 2025-03-03 | $226.00K derived: sum of 3 quarters · filed 2025-03-03 | $240.00K 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $118.00K 10-Q · filed 2023-11-09 | $153.00K derived: sum of 2 quarters · filed 2023-11-09 | $167.00K 10-Q · filed 2023-11-09 | $557.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $35.00K 10-Q · filed 2023-08-08 | $49.00K 10-Q · filed 2023-08-08 | $439.00K derived: sum of 3 quarters · filed 2024-03-19 | $505.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $14.00K 10-Q · filed 2023-05-11 | $404.00K derived: sum of 2 quarters · filed 2024-03-19 | $470.00K derived: sum of 3 quarters · filed 2024-03-19 | $809.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $456.00K derived: sum of 2 quarters · filed 2024-03-19 | $795.00K derived: sum of 3 quarters · filed 2024-03-19 | $934.00K 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | $66.00K 10-Q · filed 2022-11-09 | $405.00K derived: sum of 2 quarters · filed 2022-11-09 | $544.00K 10-Q · filed 2022-11-09 | $565.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-06-30 | $339.00K 10-Q · filed 2022-08-08 | $478.00K 10-Q · filed 2022-08-08 | $499.00K derived: sum of 3 quarters · filed 2024-03-19 | $650.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-03-31 | $139.00K 10-K · filed 2024-03-19 | $160.00K derived: sum of 2 quarters · filed 2024-03-19 | $311.00K derived: sum of 3 quarters · filed 2024-03-19 | $747.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2020-12-31 | $21.00K 10-K · filed 2021-03-04 | $172.00K derived: sum of 2 quarters · filed 2021-11-12 | $608.00K derived: sum of 3 quarters · filed 2021-11-12 | $605.00K 10-K · filed 2023-03-01 | $111.00K 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $151.00K 10-Q · filed 2021-11-12 | $68.00K 10-Q · filed 2020-11-09 | $587.00K derived: sum of 2 quarters · filed 2021-11-12 | $752.00K 10-Q · filed 2021-11-12 | $90.00K 10-Q · filed 2020-11-09 | $761.00K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $436.00K 10-Q · filed 2021-08-12 | $1.00K 10-Q · filed 2020-08-07 | $601.00K 10-Q · filed 2021-08-12 | $22.00K 10-Q · filed 2020-08-07 | $610.00K derived: sum of 3 quarters · filed 2021-08-12 | $622.00K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $165.00K 10-Q · filed 2021-05-14 | $21.00K 10-Q · filed 2020-05-11 | $174.00K derived: sum of 2 quarters · filed 2021-05-14 | $186.00K derived: sum of 3 quarters · filed 2021-05-14 | $203.00K derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $9.00K 10-K · filed 2021-03-04 | $21.00K derived: sum of 2 quarters · filed 2021-03-04 | $38.00K derived: sum of 3 quarters · filed 2021-03-04 | $2.20M 10-K · filed 2022-03-01 | $43.00K 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $12.00K 10-K · filed 2021-03-04 | $29.00K derived: sum of 2 quarters · filed 2021-03-04 | $34.00K 10-Q · filed 2020-11-09 | $41.00K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | $17.00K 10-K · filed 2021-03-04 | $22.00K 10-Q · filed 2020-08-07 | $29.00K derived: sum of 3 quarters · filed 2021-03-04 | $60.00K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $5.00K 10-K · filed 2021-03-04 | $12.00K derived: sum of 2 quarters · filed 2021-03-04 | $43.00K derived: sum of 3 quarters · filed 2021-03-04 | $47.00K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | $7.00K 10-K · filed 2020-03-25 | $38.00K derived: sum of 2 quarters · filed 2020-03-25 | $42.00K derived: sum of 3 quarters · filed 2020-03-25 | $47.00K 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $31.00K 10-K · filed 2020-03-25 | $35.00K derived: sum of 2 quarters · filed 2020-03-25 | $40.00K 10-Q · filed 2019-11-05 | $52.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-06-30 | $4.00K 10-K · filed 2020-03-25 | $9.00K 10-Q · filed 2019-08-06 | $21.00K derived: sum of 3 quarters · filed 2020-03-25 | $29.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-03-31 | $5.00K 10-K · filed 2020-03-25 | $17.00K derived: sum of 2 quarters · filed 2020-03-25 | $25.00K derived: sum of 3 quarters · filed 2020-03-25 | $39.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2017-12-31 | $12.00K 10-K · filed 2019-03-13 | $20.00K derived: sum of 2 quarters · filed 2019-03-13 | $34.00K derived: sum of 3 quarters · filed 2019-03-13 | $45.00K 10-K · filed 2020-03-25 | ||||
| 2017-09-30 | $8.00K 10-K · filed 2019-03-13 | $22.00K derived: sum of 2 quarters · filed 2019-03-13 | $33.00K 10-Q · filed 2018-11-07 | $47.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | $14.00K 10-K · filed 2019-03-13 | $25.00K 10-Q · filed 2018-08-06 | $39.00K derived: sum of 3 quarters · filed 2019-03-13 | $51.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $11.00K 10-K · filed 2019-03-13 | $25.00K derived: sum of 2 quarters · filed 2019-03-13 | $37.00K derived: sum of 3 quarters · filed 2019-03-13 | $49.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | $14.00K 10-K · filed 2018-03-12 | $26.00K derived: sum of 2 quarters · filed 2018-03-12 | $38.00K derived: sum of 3 quarters · filed 2018-03-12 | $44.00K 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $12.00K 10-K · filed 2018-03-12 | $24.00K derived: sum of 2 quarters · filed 2018-03-12 | $30.00K 10-Q · filed 2017-11-07 | $45.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $12.00K 10-K · filed 2018-03-12 | $18.00K 10-Q · filed 2017-08-07 | $33.00K derived: sum of 3 quarters · filed 2018-03-12 | $43.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $6.00K 10-K · filed 2018-03-12 | $21.00K derived: sum of 2 quarters · filed 2018-03-12 | $31.00K derived: sum of 3 quarters · filed 2018-03-12 | $122.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | $15.00K 10-K · filed 2017-03-15 | $25.00K derived: sum of 2 quarters · filed 2017-03-15 | $116.00K derived: sum of 3 quarters · filed 2017-03-15 | $236.00K 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | $10.00K 10-K · filed 2017-03-15 | $101.00K derived: sum of 2 quarters · filed 2017-03-15 | $222.00K 10-Q · filed 2016-11-10 | $319.00K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | $91.00K 10-K · filed 2017-03-15 | $211.00K 10-Q · filed 2016-08-15 | $309.00K derived: sum of 3 quarters · filed 2017-03-15 | $442.00K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | $120.00K 10-K · filed 2017-03-15 | $218.00K derived: sum of 2 quarters · filed 2017-03-15 | $351.00K derived: sum of 3 quarters · filed 2017-03-15 | $475.00K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | $98.00K 10-K · filed 2016-03-30 | $231.00K derived: sum of 2 quarters · filed 2016-03-30 | $355.00K derived: sum of 3 quarters · filed 2016-03-30 | $641.00K 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | $133.00K 10-K · filed 2016-03-30 | $257.00K derived: sum of 2 quarters · filed 2016-03-30 | $543.00K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $124.00K 10-K · filed 2016-03-30 | $410.00K 10-Q · filed 2015-09-10 | ||||||
| 2014-03-31 | $286.00K 10-K · filed 2016-03-30 | |||||||
| 2013-12-31 | $600.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |